ASHKENAZI AVI J has a total of 29 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COMMW BIOTECHNOLOGIES INC, MEINKE ANDREAS and GENE TECHNO SCIENCE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 | |
#2 | WIPO (World Intellectual Property Organization) | 8 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Machines | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Ashkenazi Avi J | 29 |
#2 | Goddard Audrey | 7 |
#3 | Wood William I | 7 |
#4 | Gurney Austin L | 7 |
#5 | Wu Thomas D | 4 |
#6 | Tumas Daniel | 4 |
#7 | Zhang Zemin | 4 |
#8 | Fong Sherman | 3 |
#9 | Eaton Dan L | 3 |
#10 | Baker Kevin P | 3 |
Publication | Filing date | Title |
---|---|---|
US2014178398A1 | Vascular disruption agents and uses thereof | |
US2008182275A1 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
US2010152426A1 | Apo-2 receptor fusion proteins | |
US2009155247A1 | Methods of Using Death Receptor Agonists and EGFR Inhibitors | |
US2006246540A1 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
US2005226868A1 | Method for treating tumors using anti-osteopontin antibodies |